# A Phase 1 Trial of GEN1119 in Participants With Solid Tumors

> **NCT07695831** · PHASE1 · RECRUITING · sponsor: **Genmab** · enrollment: 112 (estimated)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** GEN1119

## Key facts

- **NCT ID:** NCT07695831
- **Lead sponsor:** Genmab
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-13
- **Primary completion:** 2029-06
- **Final completion:** 2029-06
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695831, "A Phase 1 Trial of GEN1119 in Participants With Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*